U.S. News survey looks at how GLP-1 patients pick telehealth platforms
A 2026 U.S. News survey asks GLP-1 patients how they chose a telehealth provider and what helped them succeed.
Recap by typeshit. Full story at US News Health.
A 2026 U.S. News survey asks GLP-1 patients how they chose a telehealth provider and what helped them succeed.
Recap by typeshit. Full story at US News Health.
Keltie Knight shares a personal take on body image pressure on women, tagged with GLP-1 and BookTok. It's a short social clip with few specifics.
8:41
The weekly tirzepatide update marks a milestone for the channel, with the scale finally dipping below 220 pounds.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Loading…